Cargando…
Perceptions of Oncologists, Healthcare Policy Makers, Patients and the General Population on the Value of Pharmaceutical Treatments in Oncology
INTRODUCTION: The purpose of this study was to explore the main factors explaining the relative weight of the different attributes that determine the value of oncologic treatments from the different perspectives of healthcare policy makers (HCPM), oncologists, patients and the general population in...
Autores principales: | Sacristán, José A., Lizan, Luís, Comellas, Marta, Garrido, Pilar, Avendaño, Cristina, Cruz-Hernández, Juan J., Espinosa, Javier, Dilla, Tatiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083772/ https://www.ncbi.nlm.nih.gov/pubmed/27718158 http://dx.doi.org/10.1007/s12325-016-0415-5 |
Ejemplares similares
-
Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population
por: Dilla, Tatiana, et al.
Publicado: (2015) -
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
por: Garuba, Habibat A, et al.
Publicado: (2009) -
Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature
por: Sacristán, José Antonio, et al.
Publicado: (2020) -
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making
por: Pablos, José Luis, et al.
Publicado: (2019) -
What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis
por: Díaz-Torné, Cesar, et al.
Publicado: (2020)